Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYMulti-Site Study of COVID-19 Patients Utilizing Fluidigm Mass Cytometry Technology and Maxpar Direct Immune Profiling AssayPREV STORYBellerophon Therapeutics Added to Russell 3000® and Microcap® Indexes